Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bownes

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Brachytherapy|November 26, 2013
Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility studyJosh Mason, Bashar Al-Qaisieh, Peter Bownes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2010
Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 yearsNicholas P Munro, Bashar Al-Qaisieh, Peter Bownes, et al.
Brachytherapy|November 26, 2015
Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcomeEe Siang Choong, Peter Bownes, Hima Bindu Musunuru, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2015
A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatmentAntony L Palmer, Patricia Diez, Laura Gandon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2026
First study on the carbon footprint of UK BrachytherapyAmanda Tate, Gerry Lowe, Peter Bownes, et al.
Clinical and Translational Radiation Oncology|May 6, 2020
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancerFinbar Slevin, Samantha Hodgson, Sree Lakshmi Rodda, et al.
Clinical and Translational Radiation Oncology|November 9, 2019
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapyFinbar Slevin, Sree Lakshmi Rodda, Peter Bownes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2021
Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working GroupAngeles Rovirosa, Yaowen Zhang, Cyrus Chargari, et al.
BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2018
Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapyMonica Serban, Christian Kirisits, Richard Pötter, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Brachytherapy|November 26, 2013
Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility studyJosh Mason, Bashar Al-Qaisieh, Peter Bownes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2010
Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 yearsNicholas P Munro, Bashar Al-Qaisieh, Peter Bownes, et al.
Brachytherapy|November 26, 2015
Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcomeEe Siang Choong, Peter Bownes, Hima Bindu Musunuru, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2015
A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatmentAntony L Palmer, Patricia Diez, Laura Gandon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2026
First study on the carbon footprint of UK BrachytherapyAmanda Tate, Gerry Lowe, Peter Bownes, et al.
Clinical and Translational Radiation Oncology|May 6, 2020
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancerFinbar Slevin, Samantha Hodgson, Sree Lakshmi Rodda, et al.
Clinical and Translational Radiation Oncology|November 9, 2019
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapyFinbar Slevin, Sree Lakshmi Rodda, Peter Bownes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2021
Exclusive 3D-brachytherapy as a good option for stage-I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC-ESTRO Working GroupAngeles Rovirosa, Yaowen Zhang, Cyrus Chargari, et al.
BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2018
Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapyMonica Serban, Christian Kirisits, Richard Pötter, et al.
Pageof 5